Amalia Dolga

Amalia Dolga is a Professor at the University of Groningen, holding positions in the Faculty of Science and Engineering, the Molecular Pharmacology department of the Faculty of Medical Sciences/UMCG, and the Groningen Research Institute for Asthma and COPD (GRIAC). With 146 research outputs to her name, she maintains an active research program with publications extending into 2025, demonstrating ongoing scholarly productivity.

• University: University of Groningen
• School: Faculty of Science and Engineering
• Department: Molecular Pharmacology
• Institutional Affiliations: Faculty of Medical Sciences/UMCG, Groningen Research Institute for Asthma and COPD (GRIAC)

Professor Dolga's research spans multiple neuroscience domains with particular focus on cell death mechanisms, ferroptosis, SK channels, mitochondrial function, Alzheimer's disease, glutamic acid pathways, neuroprotective agents, and oxidative stress. Her work demonstrates a strong interdisciplinary approach connecting molecular pharmacology with neurological disorders, particularly neurodegenerative conditions. She has developed expertise in studying neuronal excitability, protein aggregation mechanisms, and mitochondrial DNA methylation.

Her recent publications reveal a consistent focus on neurodegenerative disorders with particular emphasis on Alzheimer's disease, Huntington's disease, and Parkinson's disease mechanisms. The research shows sophisticated methodologies including brain-on-a-chip models, advanced mass spectrometry techniques, and detailed cellular stress analysis. A significant trend in her work involves developing therapeutic approaches targeting specific molecular pathways in neurodegeneration.

• Stichting ParkinsonFonds Research Grant (2019)
• Alzheimer Nederland Research Grant (2018)
• Molecular Life and Health Fellowship (2017)
• ZonMw MKMD Neuro-Chip Grant (2017)
• Noordelijke Cara Stichting Grant (2016)

Professor Dolga actively supervises PhD students including Xun Zhang and has served as co-supervisor on multiple doctoral committees. Her research program has attracted substantial funding including a ZonMw Open Competition Grant for studying LRRK2 effects on neuron-microglia communication in Parkinson's disease. She has developed innovative brain-on-a-chip models for testing future therapies targeting neurodegenerative conditions.

Her laboratory work integrates molecular pharmacology with advanced cellular models, particularly focusing on mitochondrial function in neurodegeneration and the role of ion channels in neuronal health. Professor Dolga collaborates extensively with researchers across the University of Groningen including with Arjan Kortholt and Erik Boddeke on Parkinson's disease research.